Literature DB >> 18321963

Human cytomegalovirus UL97 kinase activity is required for the hyperphosphorylation of retinoblastoma protein and inhibits the formation of nuclear aggresomes.

Mark N Prichard1, Elizabeth Sztul, Shannon L Daily, Amie L Perry, Samuel L Frederick, Rachel B Gill, Caroll B Hartline, Daniel N Streblow, Susan M Varnum, Richard D Smith, Earl R Kern.   

Abstract

Cells infected with human cytomegalovirus in the absence of UL97 kinase activity produce large nuclear aggregates that sequester considerable quantities of viral proteins. A transient expression assay suggested that pp71 and IE1 were also involved in this process, and this suggestion was significant, since both proteins have been reported to interact with components of promyelocytic leukemia (PML) bodies (ND10) and also interact functionally with retinoblastoma pocket proteins (RB). PML bodies have been linked to the formation of nuclear aggresomes, and colocalization studies suggested that viral proteins were recruited to these structures and that UL97 kinase activity inhibited their formation. Proteins associated with PML bodies were examined by Western blot analysis, and pUL97 appeared to specifically affect the phosphorylation of RB in a kinase-dependent manner. Three consensus RB binding motifs were identified in the UL97 kinase, and recombinant viruses were constructed in which each was mutated to assess a potential role in the phosphorylation of RB and the inhibition of nuclear aggresome formation. The mutation of either the conserved LxCxE RB binding motif or the lysine required for kinase activity impaired the ability of the virus to stabilize and phosphorylate RB. We concluded from these studies that both UL97 kinase activity and the LxCxE RB binding motif are required for the phosphorylation and stabilization of RB in infected cells and that this effect can be antagonized by the antiviral drug maribavir. These data also suggest a potential link between RB function and the formation of aggresomes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18321963      PMCID: PMC2346732          DOI: 10.1128/JVI.02174-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  72 in total

1.  Human cytomegalovirus UL97 Kinase is required for the normal intranuclear distribution of pp65 and virion morphogenesis.

Authors:  Mark N Prichard; William J Britt; Shannon L Daily; Caroll B Hartline; Earl R Kern
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

2.  The carboxyl-terminal domain of RNA polymerase II is phosphorylated by a complex containing cdk9 and infected-cell protein 22 of herpes simplex virus 1.

Authors:  Lizette O Durand; Sunil J Advani; Alice P W Poon; Bernard Roizman
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

3.  Cellular p32 recruits cytomegalovirus kinase pUL97 to redistribute the nuclear lamina.

Authors:  Manfred Marschall; Andrea Marzi; Patricia aus dem Siepen; Ramona Jochmann; Martina Kalmer; Sabrina Auerochs; Peter Lischka; Martina Leis; Thomas Stamminger
Journal:  J Biol Chem       Date:  2005-06-23       Impact factor: 5.157

4.  Maribavir pharmacokinetics and the effects of multiple-dose maribavir on cytochrome P450 (CYP) 1A2, CYP 2C9, CYP 2C19, CYP 2D6, CYP 3A, N-acetyltransferase-2, and xanthine oxidase activities in healthy adults.

Authors:  Joseph D Ma; Anne N Nafziger; Stephen A Villano; Andrea Gaedigk; Joseph S Bertino
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

5.  Nuclear aggresomes form by fusion of PML-associated aggregates.

Authors:  Lianwu Fu; Ya-Sheng Gao; Albert Tousson; Anish Shah; Tung-Ling L Chen; Barbara M Vertel; Elizabeth Sztul
Journal:  Mol Biol Cell       Date:  2005-07-29       Impact factor: 4.138

6.  PML-RARalpha alleviates the transcriptional repression mediated by tumor suppressor Rb.

Authors:  M M Khan; T Nomura; H Kim; S C Kaul; R Wadhwa; S Zhong; P P Pandolfi; S Ishii
Journal:  J Biol Chem       Date:  2001-10-02       Impact factor: 5.157

Review 7.  DNA viruses and viral proteins that interact with PML nuclear bodies.

Authors:  R D Everett
Journal:  Oncogene       Date:  2001-10-29       Impact factor: 9.867

8.  Interactions between DNA viruses, ND10 and the DNA damage response.

Authors:  Roger D Everett
Journal:  Cell Microbiol       Date:  2006-03       Impact factor: 3.715

9.  Activity and mechanism of action of N-methanocarbathymidine against herpesvirus and orthopoxvirus infections.

Authors:  Mark N Prichard; Kathy A Keith; Debra C Quenelle; Earl R Kern
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.938

10.  Simple and highly efficient BAC recombineering using galK selection.

Authors:  Søren Warming; Nina Costantino; Donald L Court; Nancy A Jenkins; Neal G Copeland
Journal:  Nucleic Acids Res       Date:  2005-02-24       Impact factor: 16.971

View more
  70 in total

Review 1.  Progress in the development of new therapies for herpesvirus infections.

Authors:  Nathan B Price; Mark N Prichard
Journal:  Curr Opin Virol       Date:  2011-12       Impact factor: 7.090

2.  Human cytomegalovirus UL97 kinase prevents the deposition of mutant protein aggregates in cellular models of Huntington's disease and ataxia.

Authors:  Cristy Tower; Lianwu Fu; Rachel Gill; Mark Prichard; Mathieu Lesort; Elizabeth Sztul
Journal:  Neurobiol Dis       Date:  2010-08-20       Impact factor: 5.996

Review 3.  Viral serine/threonine protein kinases.

Authors:  Thary Jacob; Céline Van den Broeke; Herman W Favoreel
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

4.  Recruitment of the oncoprotein v-ErbA to aggresomes.

Authors:  Cornelius Bondzi; Abigail M Brunner; Michelle R Munyikwa; Crystal D Connor; Alicia N Simmons; Stephanie L Stephens; Patricia A Belt; Vincent R Roggero; Manohara S Mavinakere; Shantá D Hinton; Lizabeth A Allison
Journal:  Mol Cell Endocrinol       Date:  2010-11-12       Impact factor: 4.102

5.  Direct Substrate Identification with an Analog Sensitive (AS) Viral Cyclin-Dependent Kinase (v-Cdk).

Authors:  Angie C Umaña; Satoko Iwahori; Robert F Kalejta
Journal:  ACS Chem Biol       Date:  2017-12-19       Impact factor: 5.100

6.  Cyclin-dependent Kinases Phosphorylate the Cytomegalovirus RNA Export Protein pUL69 and Modulate Its Nuclear Localization and Activity.

Authors:  Sabine Rechter; Gillian M Scott; Jan Eickhoff; Katrin Zielke; Sabrina Auerochs; Regina Müller; Thomas Stamminger; William D Rawlinson; Manfred Marschall
Journal:  J Biol Chem       Date:  2009-01-29       Impact factor: 5.157

7.  Differential properties of cytomegalovirus pUL97 kinase isoforms affect viral replication and maribavir susceptibility.

Authors:  Rike Webel; Morgan Hakki; Mark N Prichard; William D Rawlinson; Manfred Marschall; Sunwen Chou
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

8.  Cell cycle-independent expression of immediate-early gene 3 results in G1 and G2 arrest in murine cytomegalovirus-infected cells.

Authors:  Lüder Wiebusch; Anke Neuwirth; Linus Grabenhenrich; Sebastian Voigt; Christian Hagemeier
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

9.  Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides.

Authors:  Mark N Prichard; Debra C Quenelle; Caroll B Hartline; Emma A Harden; Geraldine Jefferson; Samuel L Frederick; Shannon L Daily; Richard J Whitley; Kamal N Tiwari; Joseph A Maddry; John A Secrist; Earl R Kern
Journal:  Antimicrob Agents Chemother       Date:  2009-09-21       Impact factor: 5.191

10.  Inactivation of retinoblastoma protein does not overcome the requirement for human cytomegalovirus UL97 in lamina disruption and nuclear egress.

Authors:  Natalia I Reim; Jeremy P Kamil; Depeng Wang; Alison Lin; Mayuri Sharma; Maria Ericsson; Jean M Pesola; David E Golan; Donald M Coen
Journal:  J Virol       Date:  2013-02-20       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.